FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

377270003: Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    3501624018 Carbidopa 25 mg and levodopa 250 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
    3677298019 Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    46812501000001114 Co-careldopa 25mg/250mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Is a Product containing levodopa false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Is a Product containing carbidopa false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has active ingredient Carbidopa false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Is a Product containing carbidopa and levodopa false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Is a Product manufactured as oral dose form false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Is a Product containing carbidopa and levodopa in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 1
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 1
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 2
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet false Inferred relationship Existential restriction modifier 2
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has active ingredient Carbidopa false Inferred relationship Existential restriction modifier 1
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has basis of strength substance Carbidopa false Inferred relationship Existential restriction modifier 1
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has presentation strength numerator value 25 false Inferred relationship Existential restriction modifier 1
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has active ingredient Levodopa false Inferred relationship Existential restriction modifier 2
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has basis of strength substance Levodopa false Inferred relationship Existential restriction modifier 2
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has presentation strength numerator value 250 false Inferred relationship Existential restriction modifier 2
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has precise active ingredient Levodopa false Inferred relationship Existential restriction modifier 2
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has precise active ingredient Carbidopa false Inferred relationship Existential restriction modifier 1
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Is a Product containing only carbidopa and levodopa in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has active ingredient Carbidopa false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has specific active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has specific active ingredient Levodopa false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has dispensed dose form Tablet false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has specific active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has basis of strength substance Carbidopa false Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Co-careldopa 25mg/250mg tablet Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (Mawdsley-Brooks & Company Ltd) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (DE Pharmaceuticals) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (Kent Pharma (UK) Ltd) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (A A H Pharmaceuticals Ltd) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (Unichem Plc) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Sinemet 25mg/250mg tablets (Organon Pharma (UK) Ltd) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (Approved Prescription Services) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (PI) (Dowelhurst Ltd) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Sinemet 275 tablets (PI) (Dowelhurst Ltd) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets 90 tablet Is pack of False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets 100 tablet Is pack of False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets 50 tablet Is pack of False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Sinemet 275 tablets (Doncaster Pharmaceuticals Ltd) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Sinemet 275 tablets (Sigma Pharmaceuticals Plc) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (Sigma Pharmaceuticals Plc) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets 90 tablet Has VMP False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets 100 tablet Has VMP False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets 50 tablet Has VMP False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Sinemet 275 tablets (Lexon (UK) Ltd) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Sinemet 25mg/250mg tablets (Stephar (U.K.) Ltd) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Sinemet 25mg/250mg tablets (Mawdsley-Brooks & Company Ltd) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Sinemet 25mg/250mg tablets (Necessity Supplies Ltd) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Sinemet 25mg/250mg tablets (Waymade Healthcare Plc) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (Waymade Healthcare Plc) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (Zentiva Pharma UK Ltd) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (Somex Pharma) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (Bristol Laboratories Ltd) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
    Co-careldopa 25mg/250mg tablets (Genesis Pharmaceuticals Ltd) Is a False Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start